SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: jbershad who wrote (1191)3/3/1998 7:57:00 AM
From: tonyt  Read Replies (1) | Respond to of 2173
 
Looks like some of our old friends are back. Did you ever notice that he only posts here when he can gloat over other folks losses?



To: jbershad who wrote (1191)3/3/1998 8:03:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 2173
 
Actually, I posted a week or two ago when the 75% of patients still on Pramlintide was being discussed. I uploaded the press release from last August (which also mentioned 75%) and some thought that it was good news. This thread has a tendency to lose touch with reality, and when the 15 million outstanding shares was mentioned, I posted a correction and then answered questions by other posters.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News